316 related articles for article (PubMed ID: 25951434)
1. Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2015 Jun; 97():94-103. PubMed ID: 25951434
[TBL] [Abstract][Full Text] [Related]
2. Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Molecules; 2015 Apr; 20(4):6254-72. PubMed ID: 25859782
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
Kant R; Singh V; Nath G; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological action of 1-aminomethyl derivatives of 3-R-4-phenyl-delta2-1,2,4-triazoline-5-thione.
Pitucha M; Wujec M; Dobosz M; Kosikowska U; Malm A
Acta Pol Pharm; 2005; 62(6):443-9. PubMed ID: 16583983
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.
Mohammed HHH; Abdelhafez EMN; Abbas SH; Moustafa GAI; Hauk G; Berger JM; Mitarai S; Arai M; Abd El-Baky RM; Abuo-Rahma GEA
Bioorg Chem; 2019 Jul; 88():102952. PubMed ID: 31039471
[TBL] [Abstract][Full Text] [Related]
11. Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
Shavit M; Pokrovskaya V; Belakhov V; Baasov T
Bioorg Med Chem; 2017 Jun; 25(11):2917-2925. PubMed ID: 28343755
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
Wang Y; Damu GL; Lv JS; Geng RX; Yang DC; Zhou CH
Bioorg Med Chem Lett; 2012 Sep; 22(17):5363-6. PubMed ID: 22884108
[TBL] [Abstract][Full Text] [Related]
13. Substitution of terminal amide with 1H-1,2,3-triazole: Identification of unexpected class of potent antibacterial agents.
Bi F; Ji S; Venter H; Liu J; Semple SJ; Ma S
Bioorg Med Chem Lett; 2018 Mar; 28(5):884-891. PubMed ID: 29433923
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiproliferative and antimicrobial activity of new Mannich bases bearing 1,2,4-triazole moiety.
Popiołek Ł; Rzymowska J; Kosikowska U; Hordyjewska A; Wujec M; Malm A
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):786-95. PubMed ID: 24506202
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
Naresh Kumar R; Jitender Dev G; Ravikumar N; Krishna Swaroop D; Debanjan B; Bharath G; Narsaiah B; Nishant Jain S; Gangagni Rao A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2927-2930. PubMed ID: 27130357
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin derivatives and their antibacterial activities.
Zhang GF; Liu X; Zhang S; Pan B; Liu ML
Eur J Med Chem; 2018 Feb; 146():599-612. PubMed ID: 29407984
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.
Purkayastha N; Capone S; Beck AK; Seebach D; Leeds J; Thompson K; Moser HE
Chem Biodivers; 2015 Feb; 12(2):179-93. PubMed ID: 25676502
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
19. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV.
Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS
Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
